Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851459 · ClinicalTrials.gov registry record · NA
Tailoring of Vaccine-Focused Messages: Moral Foundations
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 850
- Enrollment target
NCT02851459: Completed NA study, sponsored by Emory University.
NCT02851459 is a NA study that has completed, run by Emory University. The registered enrollment target is 850 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851459, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 850 participants
- Enrollment target
Study Summary
This study is the first phase of a trial examining decision making about vaccines. This phase tests the impact of targeted vaccine-focused health messages on vaccine beliefs held by parents of young children and pre-adolescents. The participant's vaccine beliefs will be assessed at baseline. Two weeks later, the participant's moral matrix will be assessed. A vaccine-related message that appeals to the individual's three most or least emphasized moral foundations will then be presented. Immediately afterwards, vaccine beliefs will be assessed to determine the impact of the message.
Primary Outcome
Number of caregivers experiencing a change in attitude towards vaccines.
Interventions
- BEHAVIORAL Baseline Survey
- BEHAVIORAL Pre-intervention Survey
- BEHAVIORAL Morally Congruent Message
- BEHAVIORAL Morally Non-Congruent Message
- BEHAVIORAL Control Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2016-08 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02851459 record still lists
NCT02851459 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 5 interventions - of which Baseline Survey is the first listed.
NCT02851459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02851459 about?
NCT02851459 is a clinical study titled "Tailoring of Vaccine-Focused Messages: Moral Foundations". This study is the first phase of a trial examining decision making about vaccines. This phase tests the impact of targeted vaccine-focused health messages on vaccine beliefs held by parents of young children and pre-adolescents. The participant's vaccine beliefs will be assessed at baseline. Two wee...
What is the current status of trial NCT02851459?
This trial is currently completed. It is a NA study. The enrollment target is 850 participants. The study started on 2016-08. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02851459?
The interventions under investigation include: Baseline Survey (BEHAVIORAL), Pre-intervention Survey (BEHAVIORAL), Morally Congruent Message (BEHAVIORAL), Morally Non-Congruent Message (BEHAVIORAL), Control Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT02851459?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02851459's enrollment target sits among peer trials
850 131st of 2000 higher than 1,869 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia